A quantitative evaluation of the inhibition of platelet aggregation by low molecular weight degradation products of fibrinogen.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D002855:Chromatography, Thin Layer; D003094:Collagen / Q000494:pharmacology; D004347:Drug Interactions; D004586:Electrophoresis; D004837:Epinephrine / Q000494:pharmacology; D005340:Fibrinogen / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008970:Molecular Weight; D010455:Peptides / Q000494:pharmacology*; D010973:Platelet Adhesiveness / Q000187:drug effects*; D013300:Streptokinase / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology; D014462:Ultrafiltration
D010455:Peptides; D000244:Adenosine Diphosphate; D005340:Fibrinogen; D003094:Collagen; D013300:Streptokinase; D014357:Trypsin; D013917:Thrombin; D004837:Epinephrine